To enhance health product regulation, the Food and Drug Administration (FDA) has launched the task force Diomede, aimed at enhancing the classification process for borderline health products.
In a statement on April 26, the FDA, responsible for overseeing a range of health items including drugs, devices, cosmetics, hazardous substances, and food, has encountered products that cross the boundaries between these categories.
Regarding this, task force Diomede, spearheaded by FDA Director General Samuel A. Zacate, is dedicated to refining the classification procedures for such products.
It noted that the initiative aligns with the FDA's commitment to safeguarding public health through effective regulation.
The agency mentioned that currently, the task force is finalizing an FDA Circular designed to provide clear guidance to industry stakeholders.
This directive will assist manufacturers in determining the appropriate classification for their health products before seeking registration.